MPO and Insulin resistance: The increase in circulating FFA, together with SARS-CoV-2-induced GP73 production (246), metabolic factors such as MPO (191), activation of phosphoenolpyruvate carboxykinase (206), and hyperinsulinemia in response to insulin resistance, stimulate hepatic gluconeogenesis.